Lupin ropes in Abdelaziz Toumi as CEO of its API CDMO Subsidiary Ruchika Sharma18 Jun 2024 12:29 PM ISTMumbai: Global pharma major Lupin Limited has announced the appointment of Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly...
USFDA approves Merck Keytruda plus Carboplatin, Paclitaxel for Primary Advanced or Recurrent Endometrial Carcinoma Ruchika Sharma18 Jun 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved...
USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema Ruchika Sharma17 Jun 2024 3:29 PM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Himachal CM ensures State financial backing for bulk drug park project alongside Central aid to ensure timely completion Ruchika Sharma17 Jun 2024 2:14 PM ISTHimachal Pradesh: Chief Minister Thakur Sukhvinder Singh Sukhu presided over a high level meeting here to review the progress of the...
AbbVie, FutureGen ink pact to develop Next-Generation Therapy for Inflammatory Bowel Disease Ruchika Sharma17 Jun 2024 12:30 PM ISTNorth Chicago, IlI.: AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have announced a license agreement to develop FG-M701, a next...
AstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or recurrent endometrial cancer Ruchika Sharma17 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has...
USFDA issues 3 observations for Biocon Visakhapatnam API facility Ruchika Sharma16 Jun 2024 11:00 AM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded...
Takeda signs option agreement with Ascentage Pharma to enter into exclusive global license for Olverembatinib Ruchika Sharma16 Jun 2024 10:30 AM ISTJapan: Takeda has announced the signing of an option agreement with Ascentage Pharma to enter into an exclusive license agreement for...
JP Nadda, Anupriya Patel preside over review meeting of Department of Pharmaceuticals Ruchika Sharma15 Jun 2024 5:32 PM ISTNew Delhi: Union Minister for Chemicals & Fertilizers, Shri Jagat Prakash Nadda along with MoS (Chemicals & Fertilizers), Ms. Anupriya...
USFDA approves Bristol Myers Squibb Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid Tumors Ruchika Sharma15 Jun 2024 4:26 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...
Suven Pharma to buy 67.5 percent stake in Sapala Organics for Rs 229.5 crore Ruchika Sharma15 Jun 2024 2:56 PM ISTMumbai: Suven Pharmaceuticals has announced that the Company will acquire 67.5 per cent stake in Sapala Organics Private Limited for Rs 229.5...
Sun Pharma, Moebius Medical present positive data from phase 2b trial of MM-II in painful knee osteoarthritis patients at EULAR 2024 Ruchika Sharma15 Jun 2024 12:30 PM ISTSun Pharma and Moebius Medical, who have been jointly developing MM-II, have announced plans to initiate a Phase 3 clinical program.
